EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 156 filers reported holding EAGLE PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $366,006 | -62.3% | 23,209 | -30.2% | 0.01% | -64.3% |
| Q4 2022 | $972,102 | +14.1% | 33,257 | +3.1% | 0.03% | 0.0% |
| Q3 2022 | $852,000 | -37.6% | 32,245 | +4.9% | 0.03% | -30.0% |
| Q2 2022 | $1,366,000 | -7.5% | 30,746 | +3.1% | 0.04% | +33.3% |
| Q1 2022 | $1,476,000 | +50.6% | 29,834 | +30.3% | 0.03% | -3.2% |
| Q2 2021 | $980,000 | +13.3% | 22,897 | +10.5% | 0.03% | -3.1% |
| Q1 2021 | $865,000 | +31.3% | 20,727 | +46.4% | 0.03% | +3.2% |
| Q4 2020 | $659,000 | +21.4% | 14,154 | +10.7% | 0.03% | 0.0% |
| Q3 2020 | $543,000 | +99.6% | 12,786 | +125.4% | 0.03% | -31.1% |
| Q2 2020 | $272,000 | – | 5,673 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Park West Asset Management LLC | 1,120,235 | $53,749,000 | 2.66% |
| TANG CAPITAL MANAGEMENT LLC | 255,616 | $12,264,000 | 1.19% |
| Smith, Graham & Co., Investment Advisors, LP | 158,671 | $7,613,000 | 0.92% |
| ARMISTICE CAPITAL, LLC | 282,000 | $13,530,000 | 0.59% |
| Capital Impact Advisors, LLC | 35,815 | $1,718,000 | 0.57% |
| Matarin Capital Management, LLC | 58,977 | $2,830,000 | 0.56% |
| GLOBEFLEX CAPITAL L P | 31,702 | $1,521,000 | 0.39% |
| CHARTWELL INVESTMENT PARTNERS, LLC | 200,246 | $9,608,000 | 0.37% |
| Stanley-Laman Group, Ltd. | 24,000 | $1,152,000 | 0.28% |
| VIRTUS ALTERNATIVE INVESTMENT ADVISERS, INC. | 264 | $13,000 | 0.20% |